Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
Comparison of Two Routes of Surgical Approach to Lateral Cervical Node Dissection in Differentiated Thyroid Cancer Patients With Lateral Metastatic Disease: Randomized Clinical Trial
1 other identifier
interventional
62
1 country
1
Brief Summary
The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 6, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
ExpectedOctober 29, 2024
October 1, 2024
2.1 years
August 6, 2023
October 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Shoulder dysfunction
(SPADI shoulder pain and disability questionnaire, validated in Spanish) Minimun score 0, maximun 100, a higher score means higher disability
2 weeks, 3 months, 6 months, and 1 year
Cervical disconfort
The Cervical Disability Index (IDC) validated in Spanish Minimun score 0, maximun 50, a higher score means higher disability
2 weeks, 3 months, 6 months, and 1 year
Complications
Temporary or permanent accessory nerve injury measured in the physical examination by limitation of the lateral range of movement of the shoulder less than 50% * Bleeding defined by the treating surgeon by physical examination * Wound infection: infection in the first 30 days after surgery, diagnosed with at least one of the following criteria: presence of purulent discharge from the surgical wound, presence of microorganisms isolated by taking a culture of wound discharge , presence of at least one of the signs and symptoms of inflammation (pain, redness, edema, heat). * Chylous fistula defined as milky discharge from the cervical drain with a triglyceride count higher than the serum. * Mortality * Re Operation before 30 days
30 days
Secondary Outcomes (6)
Total lymph node count.
30 days
Surgical time
30 days
Lateral lymph node recurrence
5 years
Dynamic response
5 years
Overall and disease-free survival
5 years
- +1 more secondary outcomes
Study Arms (2)
Traditional neck dissection approach
ACTIVE COMPARATORTraditional neck dissection approach
Anterior neck dissection approach
EXPERIMENTALAnterior neck dissection
Interventions
.1. A transverse cervical incision is made with horizontal extension towards the affected side. 2. It is dissected through the subplatysmal plane, the posterior edge of the sternocleidomastoid muscle is dissected along its entire length. 3. Identification and dissection of the spinal nerve at Erb's point. 4. Level V nodes are dissected up to the spinal nerve without identifying or dissecting it 5. The jugular chain nodes are identified and the left level IV nodes are dissected with special attention to ligate the lymphatics of this level 6. Identification and dissection of level III nodes 7. Identification and dissection of level IIA and IIB ganglia with identification and preservation of the accessory nerve.
1. A transverse cervical incision is made with horizontal extension towards the affected side. 2. It is dissected through the subplatysmal plane, the anterior edge of the sternocleidomastoid muscle is dissected along its entire length. 3. Level V nodes are dissected up to the spinal nerve without identifying or dissecting it 4. The jugular chain nodes are identified and the left level IV nodes are dissected with special attention to ligate the lymphatics of this level 5. Identification and dissection of level III nodes 6. Identification and dissection of level IIA and IIB nodes with identification and preservation of the accessory nerve.
Eligibility Criteria
You may qualify if:
- Patients ≥ 18 years.
- Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
- Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma according to the Bethesda criteria)
- Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
- Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection
You may not qualify if:
- Patients with a history of previous neck dissection
- Histological confirmation of medullary or anaplastic carcinoma
- Previous spinal nerve injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centro de Excelencia en Enfermedades de Cabeza y Cuellolead
- Hospital Alma Mater de Antioquiacollaborator
- Hospital San Vicente Fundacióncollaborator
- Clinica Las Vegas- Grupo QuironSaludcollaborator
Study Sites (1)
Hospital Alma Mater de Antioquia
Medellín, Antioquia, 050010, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alvaro Sanabria
Universidad de Antioquia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single (Participant)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Researcher
Study Record Dates
First Submitted
August 6, 2023
First Posted
November 29, 2023
Study Start
August 1, 2023
Primary Completion
August 31, 2025
Study Completion (Estimated)
August 31, 2028
Last Updated
October 29, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share